Skip to main content
Top
Published in: Malaria Journal 1/2014

Open Access 01-12-2014 | Research

Correlation of biomarkers for parasite burden and immune activation with acute kidney injury in severe falciparum malaria

Authors: Katherine Plewes, Annick A Royakkers, Josh Hanson, Md Mahtab Uddin Hasan, Shamsul Alam, Aniruddha Ghose, Richard J Maude, Pauline M Stassen, Prakaykaew Charunwatthana, Sue J Lee, Gareth DH Turner, Arjen M Dondorp, Marcus J Schultz

Published in: Malaria Journal | Issue 1/2014

Login to get access

Abstract

Background

Acute kidney injury (AKI) complicating severe Plasmodium falciparum malaria occurs in up to 40% of adult patients. The case fatality rate reaches 75% in the absence of renal replacement therapy (RRT). The precise pathophysiology of AKI in falciparum malaria remains unclear. Histopathology shows acute tubular necrosis with localization of host monocytes and parasitized red blood cells in the microvasculature. This study explored the relationship of plasma soluble urokinase-type plasminogen activator receptor (suPAR), as a proxy-measure of mononuclear cell activation, and plasma P. falciparum histidine rich protein 2 (Pf HRP2), as a measure of sequestered parasite burden, with AKI in severe malaria.

Methods

Admission plasma suPAR and Pf HRP2 concentrations were assessed in Bangladeshi adults with severe falciparum malaria (n = 137). Patients were stratified according to AKI severity based on admission creatinine clearance.

Results

A total of 106 (77%) patients had AKI; 32 (23%), 42 (31%) and 32 (23%) were classified into ‘mild, ‘moderate’ and ‘severe’ AKI groups, respectively. Plasma suPAR and Pf HRP2 concentrations increased with AKI severity (test-for-trend P <0.0001) and correlated with other markers of renal dysfunction. Admission plasma suPAR and Pf HRP2 concentrations were higher in patients who later required RRT (P <0.0001 and P = 0.0004, respectively). In a multivariate analysis, both increasing suPAR and Pf HRP2 were independently associated with increasing urine neutrophil gelatinase-associated lipocalin concentration, a marker of acute tubular necrosis (β = 16.54 (95% CI 6.36-26.71) and β = 0.07 (0.02-0.11), respectively).

Conclusions

Both sequestered parasite burden and immune activation contribute to the pathogenesis of AKI in severe falciparum malaria.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dondorp A, Nosten F, Stepniewska K, Day NP, White NJ, South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group: Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 2005, 366: 717-725.CrossRefPubMed Dondorp A, Nosten F, Stepniewska K, Day NP, White NJ, South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group: Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 2005, 366: 717-725.CrossRefPubMed
2.
go back to reference Trang TT, Phu NH, Vinh H, Hien TT, Cuong BM, Chau TT, Mai NT, Waller DJ, White NJ: Acute renal failure in patients with severe falciparum malaria. Clin Infect Dis. 1992, 15: 874-880. 10.1093/clind/15.5.874.CrossRefPubMed Trang TT, Phu NH, Vinh H, Hien TT, Cuong BM, Chau TT, Mai NT, Waller DJ, White NJ: Acute renal failure in patients with severe falciparum malaria. Clin Infect Dis. 1992, 15: 874-880. 10.1093/clind/15.5.874.CrossRefPubMed
3.
go back to reference von Seidlein L, Olaosebikan R, Hendriksen IC, Lee SJ, Adedoyin OT, Agbenyega T, Nguah SB, Bojang K, Deen JL, Evans J, Fanello CI, Gomes E, Pedro AJ, Kahabuka C, Karema C, Kivaya E, Maitland K, Mokuolu OA, Mtove G, Mwanga-Amumpaire J, Nadjm B, Nansumba M, Ngum WP, Onyamboko MA, REyburn H, Salkulthaew T, Silamut K, Tshefu AK, Umulisa N, Gesase S, Day NP, White NJ, Dondorp AM: Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial. Clin Infect Dis. 2012, 54: 1080-1090. 10.1093/cid/cis034.PubMedCentralCrossRefPubMed von Seidlein L, Olaosebikan R, Hendriksen IC, Lee SJ, Adedoyin OT, Agbenyega T, Nguah SB, Bojang K, Deen JL, Evans J, Fanello CI, Gomes E, Pedro AJ, Kahabuka C, Karema C, Kivaya E, Maitland K, Mokuolu OA, Mtove G, Mwanga-Amumpaire J, Nadjm B, Nansumba M, Ngum WP, Onyamboko MA, REyburn H, Salkulthaew T, Silamut K, Tshefu AK, Umulisa N, Gesase S, Day NP, White NJ, Dondorp AM: Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial. Clin Infect Dis. 2012, 54: 1080-1090. 10.1093/cid/cis034.PubMedCentralCrossRefPubMed
4.
go back to reference White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu OA, Dondorp AM: Malaria. Lancet. 2013, 383: 723-735.CrossRefPubMed White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu OA, Dondorp AM: Malaria. Lancet. 2013, 383: 723-735.CrossRefPubMed
5.
go back to reference Mukherjee AP, White JC, Lau KS: Falciparum malaria associated with jaundice, renal failure and anaemia. Trans R Soc Trop Med Hyg. 1971, 65: 808-814. 10.1016/0035-9203(71)90096-4.CrossRefPubMed Mukherjee AP, White JC, Lau KS: Falciparum malaria associated with jaundice, renal failure and anaemia. Trans R Soc Trop Med Hyg. 1971, 65: 808-814. 10.1016/0035-9203(71)90096-4.CrossRefPubMed
6.
go back to reference Nguansangiam S, Day NP, Hien TT, Mai NT, Chaisri U, Riganti M, Dondorp AM, Lee SJ, Phu NH, Turner GD, White NJ, Ferguson DJ, Pongponratn E: A quantitative ultrastructural study of renal pathology in fatal Plasmodium falciparum malaria. Trop Med Int Health. 2007, 12: 1037-1050. 10.1111/j.1365-3156.2007.01881.x.CrossRefPubMed Nguansangiam S, Day NP, Hien TT, Mai NT, Chaisri U, Riganti M, Dondorp AM, Lee SJ, Phu NH, Turner GD, White NJ, Ferguson DJ, Pongponratn E: A quantitative ultrastructural study of renal pathology in fatal Plasmodium falciparum malaria. Trop Med Int Health. 2007, 12: 1037-1050. 10.1111/j.1365-3156.2007.01881.x.CrossRefPubMed
7.
go back to reference Sitprija V, Indraprasit S, Pochanugool C, Benyajati C, Piyaratn P: Renal failure in malaria. Lancet. 1967, 1: 185-188.CrossRefPubMed Sitprija V, Indraprasit S, Pochanugool C, Benyajati C, Piyaratn P: Renal failure in malaria. Lancet. 1967, 1: 185-188.CrossRefPubMed
8.
go back to reference Desakorn V, Dondorp AM, Silamut K, Pongtavornpinyo W, Sahassananda D, Chotivanich K, Pitisuttithum P, Smithyman AM, Day NP, White NJ: Stage-dependent production and release of histidine-rich protein 2 by Plasmodium falciparum. Trans R Soc Trop Med Hyg. 2005, 99: 517-524. 10.1016/j.trstmh.2004.11.014.CrossRefPubMed Desakorn V, Dondorp AM, Silamut K, Pongtavornpinyo W, Sahassananda D, Chotivanich K, Pitisuttithum P, Smithyman AM, Day NP, White NJ: Stage-dependent production and release of histidine-rich protein 2 by Plasmodium falciparum. Trans R Soc Trop Med Hyg. 2005, 99: 517-524. 10.1016/j.trstmh.2004.11.014.CrossRefPubMed
9.
go back to reference Dondorp AM, Desakorn V, Pongtavornpinyo W, Sahassananda D, Silamut K, Chotivanich K, Newton PN, Pitisuttithum P, Smithyman AM, White NJ, Day NP: Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med. 2005, 2: e204-10.1371/journal.pmed.0020204.PubMedCentralCrossRefPubMed Dondorp AM, Desakorn V, Pongtavornpinyo W, Sahassananda D, Silamut K, Chotivanich K, Newton PN, Pitisuttithum P, Smithyman AM, White NJ, Day NP: Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med. 2005, 2: e204-10.1371/journal.pmed.0020204.PubMedCentralCrossRefPubMed
10.
go back to reference Hendriksen IC, Mwanga-Amumpaire J, von Seidlein L, Mtove G, White LJ, Olaosebikan R, Lee SJ, Tshefu AK, Woodrow C, Amos B, Karema C, Saiwaew S, Maitland K, Gomes E, Pan-Ngum W, Gesase S, Silamut K, Reyburn H, Joseph S, Chotivanich K, Fanello CI, Day NP, White NJ, Dondorp AM: Diagnosing severe falciparum malaria in parasitaemic African children: a prospective evaluation of plasma PfHRP2 measurement. PLoS Med. 2012, 9: e1001297-10.1371/journal.pmed.1001297.PubMedCentralCrossRefPubMed Hendriksen IC, Mwanga-Amumpaire J, von Seidlein L, Mtove G, White LJ, Olaosebikan R, Lee SJ, Tshefu AK, Woodrow C, Amos B, Karema C, Saiwaew S, Maitland K, Gomes E, Pan-Ngum W, Gesase S, Silamut K, Reyburn H, Joseph S, Chotivanich K, Fanello CI, Day NP, White NJ, Dondorp AM: Diagnosing severe falciparum malaria in parasitaemic African children: a prospective evaluation of plasma PfHRP2 measurement. PLoS Med. 2012, 9: e1001297-10.1371/journal.pmed.1001297.PubMedCentralCrossRefPubMed
11.
go back to reference Rubach MP, Mukemba J, Florence S, John B, Crookston B, Lopansri BK, Yeo TW, Piera KA, Alder SC, Weinberg JB, Anstey NM, Granger DL, Mwaikambo ED: Plasma Plasmodium falciparum histidine-rich protein-2 concentrations are associated with malaria severity and mortality in Tanzanian children. PLoS One. 2012, 7: e35985-10.1371/journal.pone.0035985.PubMedCentralCrossRefPubMed Rubach MP, Mukemba J, Florence S, John B, Crookston B, Lopansri BK, Yeo TW, Piera KA, Alder SC, Weinberg JB, Anstey NM, Granger DL, Mwaikambo ED: Plasma Plasmodium falciparum histidine-rich protein-2 concentrations are associated with malaria severity and mortality in Tanzanian children. PLoS One. 2012, 7: e35985-10.1371/journal.pone.0035985.PubMedCentralCrossRefPubMed
12.
go back to reference Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, Piera K, Price RN, Duffull SB, Celermajer DS, Anstey NM: Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci USA. 2008, 105: 17097-17102. 10.1073/pnas.0805782105.PubMedCentralCrossRefPubMed Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, Piera K, Price RN, Duffull SB, Celermajer DS, Anstey NM: Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci USA. 2008, 105: 17097-17102. 10.1073/pnas.0805782105.PubMedCentralCrossRefPubMed
13.
go back to reference Maas RJ, Deegens JK, Wetzels JF: Serum suPAR in patients with FSGS: trash or treasure?. Pediatr Nephrol. 2013, 28: 1041-1048. 10.1007/s00467-013-2452-5.CrossRefPubMed Maas RJ, Deegens JK, Wetzels JF: Serum suPAR in patients with FSGS: trash or treasure?. Pediatr Nephrol. 2013, 28: 1041-1048. 10.1007/s00467-013-2452-5.CrossRefPubMed
14.
go back to reference Mustjoki S, Sidenius N, Vaheri A: Enhanced release of soluble urokinase receptor by endothelial cells in contact with peripheral blood cells. FEBS Lett. 2000, 486: 237-242. 10.1016/S0014-5793(00)02312-7.CrossRefPubMed Mustjoki S, Sidenius N, Vaheri A: Enhanced release of soluble urokinase receptor by endothelial cells in contact with peripheral blood cells. FEBS Lett. 2000, 486: 237-242. 10.1016/S0014-5793(00)02312-7.CrossRefPubMed
15.
go back to reference Wagner SN, Atkinson MJ, Wagner C, Hofler H, Schmitt M, Wilhelm O: Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney. Histochem Cell Biol. 1996, 105: 53-60. 10.1007/BF01450878.CrossRefPubMed Wagner SN, Atkinson MJ, Wagner C, Hofler H, Schmitt M, Wilhelm O: Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney. Histochem Cell Biol. 1996, 105: 53-60. 10.1007/BF01450878.CrossRefPubMed
16.
go back to reference Ostrowski SR, Ullum H, Goka BQ, Hoyer-Hansen G, Obeng-Adjei G, Pedersen BK, Akanmori BD, Kurtzhals JA: Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome. J Infect Dis. 2005, 191: 1331-1341. 10.1086/428854.CrossRefPubMed Ostrowski SR, Ullum H, Goka BQ, Hoyer-Hansen G, Obeng-Adjei G, Pedersen BK, Akanmori BD, Kurtzhals JA: Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome. J Infect Dis. 2005, 191: 1331-1341. 10.1086/428854.CrossRefPubMed
17.
go back to reference Perch M, Kofoed P, Fischer TK, Co F, Rombo L, Aaby P, Eugen-Olsen J: Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection. Parasite Immunol. 2004, 26: 207-211. 10.1111/j.0141-9838.2004.00695.x.CrossRefPubMed Perch M, Kofoed P, Fischer TK, Co F, Rombo L, Aaby P, Eugen-Olsen J: Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection. Parasite Immunol. 2004, 26: 207-211. 10.1111/j.0141-9838.2004.00695.x.CrossRefPubMed
18.
go back to reference Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, Krawczeski CD, Koyner JL, Murray P, Zappitelli M, Goldstein SL, Makris K, Ronco C, Martensson J, Martling CR, Venge P, Siew E, Ware LB, Ikizler TA, Mertens PR: The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol. 2011, 57: 1752-1761. 10.1016/j.jacc.2010.11.051.CrossRefPubMed Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, Krawczeski CD, Koyner JL, Murray P, Zappitelli M, Goldstein SL, Makris K, Ronco C, Martensson J, Martling CR, Venge P, Siew E, Ware LB, Ikizler TA, Mertens PR: The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol. 2011, 57: 1752-1761. 10.1016/j.jacc.2010.11.051.CrossRefPubMed
19.
go back to reference Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003, 14: 2534-2543. 10.1097/01.ASN.0000088027.54400.C6.CrossRefPubMed Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003, 14: 2534-2543. 10.1097/01.ASN.0000088027.54400.C6.CrossRefPubMed
20.
go back to reference Singer E, Marko L, Paragas N, Barasch J, Dragun D, Muller DN, Budde K, Schmidt-Ott KM: Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol (Oxf). 2013, 207: 663-672. 10.1111/apha.12054.CrossRef Singer E, Marko L, Paragas N, Barasch J, Dragun D, Muller DN, Budde K, Schmidt-Ott KM: Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol (Oxf). 2013, 207: 663-672. 10.1111/apha.12054.CrossRef
21.
go back to reference Charunwatthana P, Abul Faiz M, Ruangveerayut R, Maude RJ, Rahman MR, Roberts LJ, 2nd, Moore K, Bin Yunus E, Hoque MG, Hasan MU, Lee SJ, Pukrittayakamee S, Newton PN, White NJ, Day NP, Dondorp AM: N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial. Crit Care Med. 2009, 37: 516-522. 10.1097/CCM.0b013e3181958dfd.PubMedCentralCrossRefPubMed Charunwatthana P, Abul Faiz M, Ruangveerayut R, Maude RJ, Rahman MR, Roberts LJ, 2nd, Moore K, Bin Yunus E, Hoque MG, Hasan MU, Lee SJ, Pukrittayakamee S, Newton PN, White NJ, Day NP, Dondorp AM: N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial. Crit Care Med. 2009, 37: 516-522. 10.1097/CCM.0b013e3181958dfd.PubMedCentralCrossRefPubMed
22.
go back to reference Maude RJ, Silamut K, Plewes K, Charunwatthana P, Ho M, Abul Faiz M, Rahman R, Hossain MA, Hassan MU, Bin Yunus E, Hoque G, Islam F, Ghose A, Hanson J, Schlatter J, Lacey R, Eastaugh A, Tarning J, Lee SJ, White NJ, Chotivanich K, Day NP, Dondorp AM: Randomized controlled trial of levamisole hydrochloride as adjunctive therapy in severe falciparum malaria with high parasitemia. J Infect Dis. 2014, 209: 120-129. 10.1093/infdis/jit410.PubMedCentralCrossRefPubMed Maude RJ, Silamut K, Plewes K, Charunwatthana P, Ho M, Abul Faiz M, Rahman R, Hossain MA, Hassan MU, Bin Yunus E, Hoque G, Islam F, Ghose A, Hanson J, Schlatter J, Lacey R, Eastaugh A, Tarning J, Lee SJ, White NJ, Chotivanich K, Day NP, Dondorp AM: Randomized controlled trial of levamisole hydrochloride as adjunctive therapy in severe falciparum malaria with high parasitemia. J Infect Dis. 2014, 209: 120-129. 10.1093/infdis/jit410.PubMedCentralCrossRefPubMed
23.
go back to reference Hanson J, Hasan MM, Royakkers AA, Alam S, Charunwatthana P, Maude RJ, Douthwaite ST, Yunus EB, Mantha ML, Schultz MJ, Faiz MA, White NJ, Day NP, Dondorp AM: Laboratory prediction of the requirement for renal replacement in acute falciparum malaria. Malar J. 2011, 10: 217-10.1186/1475-2875-10-217.PubMedCentralCrossRefPubMed Hanson J, Hasan MM, Royakkers AA, Alam S, Charunwatthana P, Maude RJ, Douthwaite ST, Yunus EB, Mantha ML, Schultz MJ, Faiz MA, White NJ, Day NP, Dondorp AM: Laboratory prediction of the requirement for renal replacement in acute falciparum malaria. Malar J. 2011, 10: 217-10.1186/1475-2875-10-217.PubMedCentralCrossRefPubMed
25.
go back to reference Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron. 1976, 16: 31-41. 10.1159/000180580.CrossRefPubMed Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron. 1976, 16: 31-41. 10.1159/000180580.CrossRefPubMed
26.
go back to reference Day NP, Phu NH, Mai NT, Chau TT, Loc PP, Chuong LV, Sinh DX, Holloway P, Hien TT, White NJ: The pathophysiologic and prognostic significance of acidosis in severe adult malaria. Crit Care Med. 2000, 28: 1833-1840. 10.1097/00003246-200006000-00025.CrossRefPubMed Day NP, Phu NH, Mai NT, Chau TT, Loc PP, Chuong LV, Sinh DX, Holloway P, Hien TT, White NJ: The pathophysiologic and prognostic significance of acidosis in severe adult malaria. Crit Care Med. 2000, 28: 1833-1840. 10.1097/00003246-200006000-00025.CrossRefPubMed
27.
go back to reference Prakash J, Singh AK, Gujrati S, Maheshwari A: Acute renal failure in malaria: changing trends. Indian J Nephrol. 2002, 12: 113-117. Prakash J, Singh AK, Gujrati S, Maheshwari A: Acute renal failure in malaria: changing trends. Indian J Nephrol. 2002, 12: 113-117.
28.
go back to reference Segasothy M, Swaminathan M, Kong NC: Acute renal failure in falciparum malaria. Med J Malaysia. 1994, 49: 412-415.PubMed Segasothy M, Swaminathan M, Kong NC: Acute renal failure in falciparum malaria. Med J Malaysia. 1994, 49: 412-415.PubMed
29.
go back to reference Day NP, Phu NH, Mai NT, Bethell DB, Chau TT, Loc PP, Chuong LV, Sinh DX, Solomon T, Haywood G, Hien TT, White NJ: Effects of dopamine and epinephrine infusions on renal hemodynamics in severe malaria and severe sepsis. Crit Care Med. 2000, 28: 1353-1362. 10.1097/00003246-200005000-00016.CrossRefPubMed Day NP, Phu NH, Mai NT, Bethell DB, Chau TT, Loc PP, Chuong LV, Sinh DX, Solomon T, Haywood G, Hien TT, White NJ: Effects of dopamine and epinephrine infusions on renal hemodynamics in severe malaria and severe sepsis. Crit Care Med. 2000, 28: 1353-1362. 10.1097/00003246-200005000-00016.CrossRefPubMed
30.
go back to reference Koch A, Voigt S, Kruschinski C, Sanson E, Duckers H, Horn A, Yagmur E, Zimmermann H, Trautwein C, Tacke F: Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care. 2011, 15: R63-10.1186/cc10037.PubMedCentralCrossRefPubMed Koch A, Voigt S, Kruschinski C, Sanson E, Duckers H, Horn A, Yagmur E, Zimmermann H, Trautwein C, Tacke F: Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care. 2011, 15: R63-10.1186/cc10037.PubMedCentralCrossRefPubMed
31.
go back to reference Maas RJ, Wetzels JF, Deegens JK: Serum-soluble urokinase receptor concentration in primary FSGS. Kidney Intl. 2012, 81: 1043-1044.CrossRef Maas RJ, Wetzels JF, Deegens JK: Serum-soluble urokinase receptor concentration in primary FSGS. Kidney Intl. 2012, 81: 1043-1044.CrossRef
32.
go back to reference Outinen TK, Tervo L, Makela S, Huttunen R, Maenpaa N, Huhtala H, Vaheri A, Mustonen J, Aittoniemi J: Plasma levels of soluble urokinase-type plasminogen activator receptor associate with the clinical severity of acute Puumala hantavirus infection. PLoS One. 2013, 8: e71335-10.1371/journal.pone.0071335.PubMedCentralCrossRefPubMed Outinen TK, Tervo L, Makela S, Huttunen R, Maenpaa N, Huhtala H, Vaheri A, Mustonen J, Aittoniemi J: Plasma levels of soluble urokinase-type plasminogen activator receptor associate with the clinical severity of acute Puumala hantavirus infection. PLoS One. 2013, 8: e71335-10.1371/journal.pone.0071335.PubMedCentralCrossRefPubMed
33.
go back to reference Pawlak K, Ulazka B, Mysliwiec M, Pawlak D: Vascular endothelial growth factor and uPA/suPAR system in early and advanced chronic kidney disease patients: a new link between angiogenesis and hyperfibrinolysis?. Transl Res. 2012, 160: 346-354.CrossRefPubMed Pawlak K, Ulazka B, Mysliwiec M, Pawlak D: Vascular endothelial growth factor and uPA/suPAR system in early and advanced chronic kidney disease patients: a new link between angiogenesis and hyperfibrinolysis?. Transl Res. 2012, 160: 346-354.CrossRefPubMed
34.
go back to reference Fauser S, Deininger MH, Kremsner PG, Magdolen V, Luther T, Meyermann R, Schluesener HJ: Lesion associated expression of urokinase-type plasminogen activator receptor (uPAR, CD87) in human cerebral malaria. J Neuroimmunol. 2000, 111: 234-240. 10.1016/S0165-5728(00)00368-4.CrossRefPubMed Fauser S, Deininger MH, Kremsner PG, Magdolen V, Luther T, Meyermann R, Schluesener HJ: Lesion associated expression of urokinase-type plasminogen activator receptor (uPAR, CD87) in human cerebral malaria. J Neuroimmunol. 2000, 111: 234-240. 10.1016/S0165-5728(00)00368-4.CrossRefPubMed
35.
go back to reference Pliyev BK: Activated human neutrophils rapidly release the chemotactically active D2D3 form of the urokinase-type plasminogen activator receptor (uPAR/CD87). Mol Cell Biochem. 2009, 321: 111-122. 10.1007/s11010-008-9925-z.CrossRefPubMed Pliyev BK: Activated human neutrophils rapidly release the chemotactically active D2D3 form of the urokinase-type plasminogen activator receptor (uPAR/CD87). Mol Cell Biochem. 2009, 321: 111-122. 10.1007/s11010-008-9925-z.CrossRefPubMed
36.
go back to reference Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Fazioli F: Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J. 1996, 15: 1572-1582.PubMedCentralPubMed Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Fazioli F: Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J. 1996, 15: 1572-1582.PubMedCentralPubMed
37.
go back to reference Kwiatkowski D, Cannon JG, Manogue KR, Cerami A, Dinarello CA, Greenwood BM: Tumour necrosis factor production in falciparum malaria and its association with schizont rupture. Clin Exp Immunol. 1989, 77: 361-366.PubMedCentralPubMed Kwiatkowski D, Cannon JG, Manogue KR, Cerami A, Dinarello CA, Greenwood BM: Tumour necrosis factor production in falciparum malaria and its association with schizont rupture. Clin Exp Immunol. 1989, 77: 361-366.PubMedCentralPubMed
38.
go back to reference Polimeni M, Valente E, Aldieri E, Khadjavi A, Giribaldi G, Prato M: Haemozoin induces early cytokine-mediated lysozyme release from human monocytes through p38 MAPK- and NF-kappaB-dependent mechanisms. PLoS One. 2012, 7: e39497-10.1371/journal.pone.0039497.PubMedCentralCrossRefPubMed Polimeni M, Valente E, Aldieri E, Khadjavi A, Giribaldi G, Prato M: Haemozoin induces early cytokine-mediated lysozyme release from human monocytes through p38 MAPK- and NF-kappaB-dependent mechanisms. PLoS One. 2012, 7: e39497-10.1371/journal.pone.0039497.PubMedCentralCrossRefPubMed
40.
go back to reference Endre ZH, Pickering JW: Biomarkers and creatinine in AKI: the trough of disillusionment or the slope of enlightenment?. Kidney Intl. 2013, 84: 644-647. 10.1038/ki.2013.168.CrossRef Endre ZH, Pickering JW: Biomarkers and creatinine in AKI: the trough of disillusionment or the slope of enlightenment?. Kidney Intl. 2013, 84: 644-647. 10.1038/ki.2013.168.CrossRef
Metadata
Title
Correlation of biomarkers for parasite burden and immune activation with acute kidney injury in severe falciparum malaria
Authors
Katherine Plewes
Annick A Royakkers
Josh Hanson
Md Mahtab Uddin Hasan
Shamsul Alam
Aniruddha Ghose
Richard J Maude
Pauline M Stassen
Prakaykaew Charunwatthana
Sue J Lee
Gareth DH Turner
Arjen M Dondorp
Marcus J Schultz
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2014
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-13-91

Other articles of this Issue 1/2014

Malaria Journal 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.